Inventor
YIMIN QIAN
Inventor
US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides7%
C07CAcyclic or carbocyclic compounds2%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
C02FTreatment of water, waste water, sewage, or sludge1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
G06FElectric digital data processing1%
PatentTitleYear
12,577,255MDM2-based modulators of proteolysis and associated methods of use202612,569,464Protein-protein interaction inducing technology202612,473,223Intelligent wastewater purification and treatment device202512,441,708Cereblon ligands and bifunctional compounds comprising the same202512,338,248Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors202512,312,316Compounds and methods for the targeted degradation of androgen receptor202512,275,716Modulators of estrogen receptor proteolysis and associated methods of use202512,264,157Compounds and methods for the enhanced degradation of targeted proteins202512,239,711Cereblon ligands and bifunctional compounds comprising the same202512,211,126Run-length stripping method for generating skeleton lines of complex plain river networks202512,208,095Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders202512,195,459Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof202512,171,831Compounds and methods for the targeted degradation of bromodomain- containing proteins202412,172,981Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders202412,168,058Glutarimide-containing KRAS-mutant degrader compounds and uses thereof202412,110,291Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof202411,857,519Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide202411,642,342Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer202311,597,720Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders202311,584,743Indole derivatives as estrogen receptor degraders202311,554,171Compounds and methods for the targeted degradation of bromodomain-containing proteins202311,535,606Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof202211,530,222Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degraders202211,512,083Compounds and methods for the enhanced degradation of targeted proteins202211,427,548Compounds and methods for the targeted degradation of androgen receptor202211,420,956Ureas having Androgen Receptor degradation activity and uses thereof202211,384,063Modulators of estrogen receptor proteolysis and associated methods of use202211,352,351Compounds and methods for the targeted degradation of androgen receptor202211,312,702Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof202211,261,178Chroman derivatives having estrogen receptor degradation activity and uses thereof202211,220,490Ureas having androgen receptor degradation activity and uses thereof202211,191,741Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to ARVINAS OPERATIONS INC (19)· patent assignee history
2021–2026Based in US· patent location history
2022–2025Patents assigned to ACCUTAR BIOTECHNOLOGY INC (7)· patent assignee history
2022–2025Patents assigned to UNIV YALE (4)· patent assignee history
2024–2025Patents assigned to TIGER BIOTHERAPEUTICS INC (3)· patent assignee history
2025Patents assigned to ZHEJIANG INST OF HYDRAULICS & ESTUARY ZHEJIANG INST OF MARINE PLANNING AND DESIGN (2)· patent assignee history
2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARVINAS OPERATIONS INC | 19 | 2021–2026 |
| ACCUTAR BIOTECHNOLOGY INC | 7 | 2022–2025 |
| UNIV YALE | 4 | 2022–2025 |
| TIGER BIOTHERAPEUTICS INC | 3 | 2024–2025 |
| ZHEJIANG INST OF HYDRAULICS & ESTUARY ZHEJIANG INST OF MARINE PLANNING AND DESIGN | 2 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 30 | 2021–2026 |
| CN | 2 | 2025 |